[1] W.R. Gibb, A.J. Lees, The relevance of the Lewy body to the pathogenesis of idio- pathic Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry 51 (1998) 745–752.
[2] M.M. Hoehn, M.D. Yahr, Parkinsonism: onset, progression and mortality, Neurology 17 (1967) 427–442.
[3] L.V. Kalia, A.E. Lang, Parkinson’s disease, Lancet 386 (2015) 896–912.
[4] K.R. Chaudhuri, P. Odin, A. Antonini, P. Martinez-Martin, Parkinson’s disease: the non-motor issues, Parkinsonism Relat. Disord. 17 (2011) 717–723.
[5] N.J. Weerkamp, G. Tissingh, P.J. Poels, et al., Nonmotor symptoms in nursing home residents with Parkinson’s disease: prevalence and effect on quality of life, J. Am. Geriatr. Soc. 61 (2013) 1714–1721.
[6] P. Barone, A. Antonini, C. Colosimo, et al., The PRIAMO study: a multicenter as- sessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease, Mov. Disord. 24 (2009) 1641–1649.
[7] P. Martinez-Martin, C. Rodriguez-Blazquez, M.M. Kurtis, K.R. Chaudhuri, The im- pact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease, Mov. Disord. 26 (2011) 399–406.
[8] W. Song, X. Guo, K. Chen, et al., The impact of non-motor symptoms on the health- related quality of life of Parkinson’s disease patients from Southwest China, Parkinsonism Relat. Disord. 20 (2014) 149–152.
[9] D. Santos-Garcia, R. de la Fuente-Fernandez, Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease, J. Neurol. Sci. 332 (2013) 136–140.
[10] K.M. Prakash, N.V. Nadkarni, W.K. Lye, M.H. Yong, E.K. Tan, The impact of non- motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study, Eur. J. Neurol. 23 (2016) 854–860.
[11] S.E. Soh, M.E. Morris, J.L. McGinley, Determinants of health-related quality of life in Parkinson’s disease: a systematic review, Parkinsonism Relat. Disord. 17 (2011) 1–9.
[12] P. Martinez-Martin, The importance of non-motor disturbances to quality of life in Parkinson’s disease, J. Neurol. Sci. 310 (2011) 12–16.
[13] T.A. Zesiewicz, K.L. Sullivan, I. Arnulf, et al., Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology 74 (2010) 924–931.
[14] K.R. Chaudhuri, C. Prieto-Jurcynska, Y. Naidu, et al., The nondeclaration of non- motor symptoms of Parkinson’s disease to health care professionals: an interna- tional study using the nonmotor symptoms questionnaire, Mov. Disord. 25 (2010) 704–709.
[15] L.M. Shulman, R.L. Taback, A.A. Rabinstein, W.J. Weiner, Non-recognition of de- pression and other non-motor symptoms in Parkinson’s disease, Parkinsonism Relat. Disord. 8 (2002) 193–197.
[16] K.R. Chaudhuri, D.G. Healy, A.H. Schapira, Non-motor symptoms of Parkinson’s disease: diagnosis and management, Lancet Neurol. 5 (2006) 235–245.
[17] B.S. Connolly, A.E. Lang, Pharmacological treatment of Parkinson disease: a review, JAMA 311 (2014) 1670–1683.
[18] L.M. Shulman, R.L. Taback, J. Bean, W.J. Weiner, Comorbidity of the nonmotor symptoms of Parkinson’s disease, Mov. Disord. 16 (2001) 507–510.
[19] P. Martinez-Martin, A.H. Schapira, F. Stocchi, et al., Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients, Mov. Disord. 22 (2007) 1623–1629.
[20] L. Kadastik-Eerme, M. Muldmaa, S. Lilles, M. Rosenthal, N. Taba, P. Taba, Nonmotor features in Parkinson’s disease: what are the Most important associated factors? Parkinson’s Dis. 2016 (2016) 4370674.
[21] A. Yoritaka, Y. Shimo, M. Takanashi, et al., Motor and non-motor symptoms of 1453 patients with Parkinson’s disease: prevalence and risks, Parkinsonism Relat. Disord. 19 (2013) 725–731.
[22] X. Guo, W. Song, K. Chen, et al., Gender and onset age-related features of non-motor symptoms of patients with Parkinson’s disease-a study from Southwest China, Parkinsonism Relat. Disord. 19 (2013) 961–965.
[23] H.S. Kim, S.M. Cheon, J.W. Seo, H.J. Ryu, K.W. Park, J.W. Kim, Nonmotor symp- toms more closely related to Parkinson’s disease: comparison with normal elderly, J. Neurol. Sci. 324 (2013) 70–73.
[24] X. Guo, W. Song, K. Chen, et al., Disease duration-related differences in non-motor symptoms: a study of 616 Chinese Parkinson’s disease patients, J. Neurol. Sci. 330 (2013) 32–37.
[25] S. Krishnan, G. Sarma, S. Sarma, A. Kishore, Do nonmotor symptoms in Parkinson’s disease differ from normal aging? Mov. Disord. 26 (2011) 2110–2113.
[26] P. Martinez-Martin, C. Falup Pecurariu, P. Odin, et al., Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease, J. Neurol. 259 (2012) 1639–1647.
[27] Y. Wu, X.Y. Guo, Q.Q. Wei, et al., Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson’s disease patients, Acta Neurol. Scand. 133 (2016) 330–337.
[28] K. Szewczyk-Krolikowski, P. Tomlinson, K. Nithi, et al., The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial find- ings from the Oxford Parkinson Disease Center (OPDC) discovery cohort, Parkinsonism Relat. Disord. 20 (2014) 99–105.
[29] K.C. Breen, G. Drutyte, Non-motor symptoms of Parkinson’s disease: the patient’s perspective, J. Neural Transm. 120 (2013) 531–535.
[30] M.Z. Zhou, J. Gan, Y.R. Wei, X.Y. Ren, W. Chen, Z.G. Liu, The association between non-motor symptoms in Parkinson’s disease and age at onset, Clin. Neurol. Neurosurg. 115 (2013) 2103–2107.
[31] M. Picillo, A. Nicoletti, V. Fetoni, B. Garavaglia, P. Barone, M.T. Pellecchia, The relevance of gender in Parkinson’s disease: a review, J. Neurol. 264 (2017) 1583–1607.
[32] M. Picillo, M. Amboni, R. Erro, et al., Gender differences in non-motor symptoms in early, drug naive Parkinson’s disease, J. Neurol. 260 (2013) 2849–2855.
[33] T. Maeda, Y. Shimo, S.W. Chiu, et al., Clinical manifestations of nonmotor symp- toms in 1021 Japanese Parkinson’s disease patients from 35 medical centers, Parkinsonism Relat. Disord. 38 (2017) 54–60.
[34] P. Solla, A. Cannas, F.C. Ibba, et al., Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson’s disease, J. Neurol. Sci. 323 (2012) 33–39.
[35] E.M. Khedr, N.A. El Fetoh, H. Khalifa, M.A. Ahmed, K.M. El Beh, Prevalence of non motor features in a cohort of Parkinson’s disease patients, Clin. Neurol. Neurosurg. 115 (2013) 673–677.
[36] A. Nicoletti, R. Vasta, G. Mostile, et al., Gender effect on non-motor symptoms in Parkinson’s disease: are men more at risk? Parkinsonism Relat. Disord. 35 (2017) 69–74.
[37] M.H. Katz, Multivariable Analysis : A Practical Guide for Clinicians, Cambridge University Press, Cambridge, UK, 1999.
[38] K.R. Chaudhuri, P. Martinez-Martin, R.G. Brown, et al., The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an interna- tional pilot study, Mov. Disord. 22 (2007) 1901–1911.
[39] P. Martinez-Martin, C. Rodriguez-Blazquez, K. Abe, et al., International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease, Neurology 73 (2009) 1584–1591.
[40] G.T. Stebbins, C.G. Goetz, D.J. Burn, J. Jankovic, T.K. Khoo, B.C. Tilley, How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale, Mov. Disord. 28 (2013) 668–670.
[41] H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, E. Braak, Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiol. Aging 24 (2003) 197–211.
[42] P. Mahlknecht, K. Seppi, W. Poewe, The concept of prodromal Parkinson’s disease, J. Parkinsons Dis. 5 (2015) 681–697.
[43] M.S. Okun, Management of Parkinson Disease in 2017: personalized approaches for patient-specific needs, JAMA 318 (2017) 791–792.
[44] D. Berg, R.B. Postuma, B. Bloem, et al., Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson’s disease, Mov. Disord. 29 (2014) 454–462.